论文信息 - Nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients with advanced solid tumors: Survival and long-term safety in a phase I trial. - 字舞流文

Nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients with advanced solid tumors: Survival and long-term safety in a phase I trial.

J. Taube | J. Sosman | F. Hodi | M. Sznol | J. Wigginton | A. Gupta | S. Topalian | D. Spigel | G. Kollia | S. Antonia | J. Brahmer | J. Powderly | S. Gettinger | Drew M. Pardoll | David F. McDermott | Donald P. Lawrence | Richard D. Carvajal | Charles G. Drake | David C. Smith | Michael B Atkins